Multivariable Cox regression analysis of EFS
| Covariate . | Hazard ratio (95% CI) . | P value . |
|---|---|---|
| Age (ref ≤10 y) | 0.92 (0.69-1.23) | .573 |
| Sex (ref = male) | 1.21 (0.89-1.65) | .224 |
| Race (ref = White) | ||
| Black | 1.10 (0.73-1.65) | .647 |
| Other | 1.18 (0.70-1.99) | .533 |
| WBC (ref ≤200 × 103) | 1.61 (1.19-2.18) | .002 |
| Day-29 MRD (ref ≤0.1%) | 3.06 (2.18-4.28) | <.0001 |
| ETP status (ref = non-ETP) | ||
| ETP | 0.80 (0.51-1.28) | .358 |
| Near-ETP | 0.79 (0.53-1.17) | .238 |
| Day-8 PB MRD (ref ≤0.01%) | 1.18 (0.63-2.22) | .597 |
| Day-15 BM MRD (ref ≤0.001%) | 1.08 (0.67-1.74) | .750 |
| Covariate . | Hazard ratio (95% CI) . | P value . |
|---|---|---|
| Age (ref ≤10 y) | 0.92 (0.69-1.23) | .573 |
| Sex (ref = male) | 1.21 (0.89-1.65) | .224 |
| Race (ref = White) | ||
| Black | 1.10 (0.73-1.65) | .647 |
| Other | 1.18 (0.70-1.99) | .533 |
| WBC (ref ≤200 × 103) | 1.61 (1.19-2.18) | .002 |
| Day-29 MRD (ref ≤0.1%) | 3.06 (2.18-4.28) | <.0001 |
| ETP status (ref = non-ETP) | ||
| ETP | 0.80 (0.51-1.28) | .358 |
| Near-ETP | 0.79 (0.53-1.17) | .238 |
| Day-8 PB MRD (ref ≤0.01%) | 1.18 (0.63-2.22) | .597 |
| Day-15 BM MRD (ref ≤0.001%) | 1.08 (0.67-1.74) | .750 |
ref, reference.